AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
New Fortress Energy
NFE
Cars.com
CARS
4
Halozyme Therapeutics
HALO
5
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -49.96%53.95M | 99.43%16.34M | -81.09%5.57M | -93.97%2.05M | -17.01%29.98M | -26.82%107.8M | -82.54%8.19M | -40.70%29.48M | 11.30%34M | 79.44%36.13M |
Net income from continuing operations | -22.29%62.2M | -5.03%17.7M | -20.78%14.89M | -29.92%14.45M | -31.04%15.16M | -21.06%80.04M | -34.57%18.63M | -30.82%18.8M | -17.68%20.62M | 6.26%21.99M |
Operating gains losses | 29.90%-5.46M | 106.33%342K | -59.30%-1.87M | -404.86%-2.01M | -3.00%-1.93M | 17.84%-7.79M | -179.62%-5.41M | 47.91%-1.17M | 123.76%659K | 25.86%-1.87M |
Depreciation and amortization | -4.84%6.46M | -1.46%1.62M | -3.09%1.63M | -6.67%1.61M | -7.92%1.6M | -45.15%6.79M | -16.02%1.64M | 98.47%1.69M | -51.50%1.73M | -71.08%1.74M |
Other non cashItems | 358.96%1.94M | 2,995.81%19.94M | -411.55%-21.48M | -92.37%-5.45M | 58.27%8.92M | -105.07%-748K | -83.63%644K | -139.14%-4.2M | -1,908.51%-2.83M | 2,201.22%5.64M |
Change in working capital | -207.52%-21.94M | -343.52%-25.89M | 9.32%8.57M | -171.39%-9.15M | -19.14%4.52M | -6.21%20.41M | -145.96%-5.84M | -30.17%7.84M | 592.49%12.81M | 239.11%5.59M |
-Change in receivables | -199.32%-9.72M | -241.73%-1.79M | -368.65%-3.84M | -287.82%-5.79M | -80.12%1.71M | -60.37%9.78M | -86.11%1.26M | -82.77%1.43M | -144.52%-1.49M | 8.56%8.59M |
-Change in prepaid assets | 119.97%5.78M | 145.14%2.84M | ---- | ---- | 285.47%5.56M | -17.58%-28.94M | -98.61%-6.29M | ---- | ---- | ---3M |
-Change in other current liabilities | -142.55%-17.17M | ---- | ---- | -122.73%-2.95M | -986.23%-2.45M | 80.78%40.35M | ---- | ---- | 70.51%12.99M | -86.61%276K |
-Change in other working capital | -5.31%-833K | -2,331.03%-647K | -13.62%-317K | 260.52%435K | -12.59%-304K | -23.79%-791K | -70.10%29K | -13.41%-279K | -10.16%-271K | -10.66%-270K |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | -49.96%53.95M | 99.43%16.34M | -81.09%5.57M | -93.97%2.05M | -17.01%29.98M | -26.82%107.8M | -82.54%8.19M | -40.70%29.48M | 11.30%34M | 79.44%36.13M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 48.82%-107.47M | 107.79%13.2M | -80.54%-103.25M | -118.00%-7.94M | 65.38%-9.49M | 76.18%-209.99M | 5.13%-169.54M | 64.49%-57.19M | 113.18%44.13M | 86.76%-27.4M |
Net investment purchase and sale | -672.17%-40.2M | -70.45%-17.73M | -33.88%-2.87M | -123.49%-7.42M | -1.55%-12.19M | 111.60%7.03M | 15.35%-10.4M | 83.65%-2.14M | 304.14%31.57M | 39.20%-12.01M |
Net proceeds payment for loan | 68.57%-69.73M | 118.76%29.5M | -62.40%-102.97M | -98.24%240K | 123.69%3.5M | 72.94%-221.83M | 5.87%-157.26M | 57.04%-63.4M | 104.27%13.6M | 92.08%-14.77M |
Net PPE purchase and sale | -96.20%183K | 55.37%-839K | -69.05%2.59M | 26.48%-769K | -28.69%-794K | 349.74%4.81M | -968.18%-1.88M | 2,493.41%8.35M | -33.42%-1.05M | 0.00%-617K |
Net other investing changes | --2.27M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 48.82%-107.47M | 107.79%13.2M | -80.54%-103.25M | -118.00%-7.94M | 65.38%-9.49M | 76.18%-209.99M | 5.13%-169.54M | 64.49%-57.19M | 113.18%44.13M | 86.76%-27.4M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 7.50%56M | -107.16%-12.51M | 356.69%72.36M | 152.70%62.93M | -366.63%-66.78M | -89.09%52.1M | -16.45%174.66M | -116.66%-28.19M | -157.12%-119.42M | 122.83%25.05M |
Increase decrease in deposit | 37.95%155.2M | 58.79%32.56M | 232.65%73.88M | -140.72%-46.72M | 189.65%95.49M | -70.53%112.5M | 161.56%20.5M | -125.09%-55.7M | -41.53%114.73M | 1,163.76%32.97M |
Net issuance payments of debt | -150.00%-62.5M | -123.08%-37.5M | -80.00%7.5M | 153.33%120M | ---152.5M | -119.97%-25M | -35.00%162.5M | 183.33%37.5M | -1,225.00%-225M | --0 |
Net commonstock issuance | -54.60%-6.31M | 25.03%-554K | 39.93%-916K | -78.57%-3.25M | ---1.59M | ---4.08M | ---739K | -368.01%-1.53M | ---1.82M | --0 |
Cash dividends paid | 0.51%-30.38M | 0.63%-7.54M | 1.63%-7.57M | 0.59%-7.59M | -0.83%-7.69M | -6.63%-30.54M | 0.38%-7.59M | -0.91%-7.69M | -13.83%-7.63M | -13.93%-7.62M |
Proceeds from stock option exercised by employees | --582K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --822K |
Net other financing activities | 25.35%-586K | -528.57%-44K | ---- | ---- | 56.17%-490K | -7.24%-785K | 75.00%-7K | ---- | ---- | -734.33%-1.12M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 7.50%56M | -107.16%-12.51M | 356.69%72.36M | 152.70%62.93M | -366.63%-66.78M | -89.09%52.1M | -16.45%174.66M | -116.66%-28.19M | -157.12%-119.42M | 122.83%25.05M |
Net cash flow | ||||||||||
Beginning cash position | -14.22%302.32M | -0.43%287.77M | -9.23%313.08M | -33.70%256.04M | -14.22%302.32M | -42.13%352.42M | 5.03%289.01M | 58.77%344.91M | 23.59%386.2M | -42.13%352.42M |
Current changes in cash | 104.94%2.48M | 27.89%17.03M | 54.72%-25.31M | 238.13%57.04M | -237.02%-46.29M | 80.47%-50.1M | -82.76%13.32M | -196.51%-55.9M | 56.65%-41.29M | 111.39%33.78M |
End cash position | 0.82%304.8M | 0.82%304.8M | -0.43%287.77M | -9.23%313.08M | -33.70%256.04M | -14.22%302.32M | -14.22%302.32M | 5.03%289.01M | 58.77%344.91M | 23.59%386.2M |
Free cash flow | -51.30%51.33M | 153.92%15.5M | -82.61%5.36M | -96.11%1.28M | -17.80%29.19M | -27.52%105.38M | -86.94%6.1M | -37.58%30.81M | 10.72%32.96M | 81.95%35.51M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |